Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Debt to Equity (2022 - 2025)

Celularity (CELU) has disclosed Debt to Equity for 4 consecutive years, with -$0.0 as the latest value for Q4 2025.

  • For Q4 2025, Debt to Equity fell 100.06% year-over-year to -$0.0; the TTM value through Dec 2025 reached -$0.0, down 100.06%, while the annual FY2025 figure was -$0.0, 100.06% down from the prior year.
  • Debt to Equity hit -$0.0 in Q4 2025 for Celularity, up from -$0.21 in the prior quarter.
  • Across five years, Debt to Equity topped out at $4.35 in Q4 2024 and bottomed at -$7.38 in Q1 2025.
  • Average Debt to Equity over 4 years is -$0.29, with a median of $0.19 recorded in 2022.
  • Year-over-year, Debt to Equity surged 933.74% in 2024 and then tumbled 100.06% in 2025.
  • Celularity's Debt to Equity stood at $0.19 in 2022, then surged by 122.41% to $0.42 in 2023, then soared by 933.74% to $4.35 in 2024, then crashed by 100.06% to -$0.0 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at -$0.0, -$0.21, and -$1.6 for Q4 2025, Q3 2025, and Q2 2025 respectively.